Synthesis and biological activity of hydroxamic acid-derived vasopeptidase inhibitor analogues.
[structure: see text] Syntheses of novel hydroxamic acid-derived azepinones containing pendant mercaptoacyl groups or formyl hydroxamates are described. These new analogues of therapeutically important ACE and NEP inhibitors include unprecedented changes at the previously assumed essential acid component.